胰岛素抵抗在慢性胰腺炎及胰腺癌中的作用机制

李永康; 杨能红

doi:10.3969/j.issn.1001-5256.2020.11.053

胰岛素抵抗在慢性胰腺炎及胰腺癌中的作用机制

DOI: 10.3969/j.issn.1001-5256.2020.11.053

贵州医科大学

详细信息

中图分类号: R576;R735.9
计量
- 文章访问数: 946
- HTML全文浏览量: 41
- PDF下载量: 86
- 被引次数: 0
出版历程
- 收稿日期: 2020-04-16
- 出版日期: 2020-11-20

Research advances in insulin resistance in chronic pancreatitis and pancreatic cancer

Guizhou Medical University

摘要

摘要:
胰岛素抵抗是继发于胰腺疾病的一种糖代谢障碍表现,既往研究显示其与炎症因子及肿瘤进展相关。归纳了胰岛素抵抗在慢性胰腺炎、胰腺癌中的作用机制及影响,认为进一步研究胰岛素抵抗可为慢性胰腺炎的预防和胰腺癌的进展及预后评估提供有效依据。
- 胰腺炎,慢性 /
- 胰腺肿瘤 /
- 胰岛素抵抗
Abstract:
Insulin resistance is a manifestation of glucose metabolism disorder secondary to pancreatic disease,and previous studies have shown that it is associated with inflammatory factors and tumor progression. This article reviews the mechanism and influence of insulin resistance in chronic pancreatitis and pancreatic cancer and points out that further research on insulin resistance can provide an effective basis for the prevention of chronic pancreatitis and the evaluation of the progression and prognosis of pancreatic cancer.
- pancreatitis,chronic /
- pancreatic neoplasms /
- insulin resistance

HTML全文

参考文献(36)

[1] PETESEN MC,SHULMAN GI. Mechanisms of insulin action and insulin resistance[J]. Physiol Rev,2018,98(4):2133-2223.

[2] SINGH VK,YADAV D. Diagnosis and management of chronic pancreatitis:A review[J]. JAMA,2019,322(24):2422-2434.

[3] KIRKEGARD J,CRONIN FD,HEIDE JU,et al. Acute pancreatitis and pancreatic cancer risk:A nationwide matched-cohort study in Denmark[J]. Gastroenterology,2018,154(6):1729-1736.

[4] KUMAR KV,MANRAI M,SOOD AK,et al. A clinical study of insulin resistance in patients with chronic pancreatitis[J]. Diabetes Metab Syndr,2017,11(Suppl 1):s283-s286.

[5] YANG J,WALDRON RT,SU HY,et al. Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells[J]. Am J Physiol Gastrointest Liver Physiol,2016,311(4):g675-g687.

[6] TU J,YANG Y,ZHANG J,et al. Regulatory effect of chemerin and therapeutic efficacy of chemerin9 in pancreatogenic diabetes mellitus[J]. Mol Med Rep,2020,21(3):981-988.

[7] ZHOU N,YANG XZ. Metabonomics-based methods for metabolic disease:Research advances[J]. J Int Pharm Res,2015,42(5):561-567.(in Chinese)周宁，颜贤忠．代谢性疾病的代谢组学研究进展[J]．国际药学研究杂志，2015,42(5):561-567.

[8] TU J,ZHANG J,KE L,et al. Endocrine and exocrine pancreatic insufficiency after acute pancreatitis:Long-term followup study[J]. BMC Gastroenterol,2017,17(1):114-122.

[9] YUAN XL,ZHU XY,LI L. Research progress of the correlation of chronic pancreatitis and type 3c diabetes mellitus[J]. Chin Gen Pract,2017,20(25):3184-3186.(in Chinese)袁雪璐，祝祥云，李玲．慢性胰腺炎与3c型糖尿病相关性的研究进展[J]．中国全科医学，2017,20(25):3184-3186.

[10] HONZAWA N,FUJIMOTO K,KITAMURA T. Mechanisms of insulin action and insulin resistance[J]. Physiol Rev,2018,98(4):2133-2223.

[11] AKHTAR DH,IQBAL U,VAZQUEZ M,et al. Pathogenesis of insulin resistance and atherogenic dyslipidemia in non malcoholic fatty liver disease[J]. J Clin Transl Hepatol,2019,7(4):362-370.

[12] SLIWINSKA MM. Distribution of pancreatic polypeptide-secreting endocrine cells in nondiabetic and diabetic cases[J].Appl Immunohistochem Mol Morphol,2017,25(6):422-431.

[13] LIN YK,JOHNSTON PC,ARCE K,et al. Chronic pancreatitis and diabetes mellitus[J]. Curr Treat Options Gastroenterol,2015,13(3):319-331.

[14] HUANG CT,LIN CK,LEE TH,et al. Pancreatic fibrosis and chronic pancreatitis:Mini-review of non-histologic diagnosis for clinical applications[J]. Diagnostics(Basel),2020,10(2):87.

[15] LUO C,YANG H,TANG C,et al. Kaempferol alleviates insulin resistance via hepatic IKK/NF-kappaB slgnal inty Pe2 diabetic rats[J]. Int Immunopharmacol,2015,28(1):744-750.

[16] SOLINAS G,BECATTINI B. JNK at the crossroad of obesity,insulin resistance,and cell stress response[J]. Mol Metab,2016,6(2):174-184.

[17] LU L,YE X,YAO Q,et al. Egr2 enhances insulin resistance Via JAK2/STAT3/SOCS-1 Pathway in HepG2 cells treated with palmitate[J]. Gen Comp Endocrinol,2018,260:25-31.

[18] LU H,BOGDANOVIC E,YU Z,et al. Combined hy Perglycemia and hy Perinsullinemia-induced insulin resistance in adiPocytes is associated with dual signaling defects mediated by PKc-zeta[J]. Endocrinology,2018,159(4):1658-1677.

[19] ZANOTTO TM,QUARESMA P,GUADAGNINI D,et al. Blocking i NOS and endoPlasmic reticulum stress synergistically imProves insulin resistance in mice[J]. Mol Metab,2016,6(2):206-218.

[20] TANGVARASMICHAI S. Oxidative stress,insulin resistance,dyslipidemia and tr Pe 2 diabetes mellitus[J]. World J Diabetes,20l5,6(3):456-480.

[21] DAS P,BISWAS S,MUKHERJEE S,et al. Association of oxidative stress and obesity with insulin resistance in ty Pe 2 diabetes mellitus[J]. Mymensingh Med J,2016,25(1):148-152.

[22] GILLIES NA,PENDHARKAR SA,SINGH RG,et al. Lipid metabolism in patients with chronic hyperglycemia after an episode of acute pancreatitis[J]. Diabetes Metab Syndr,2016,11(s1):s233-s241.

[23] ALBAI O,ROMAN D. Hypertriglyceridemia,an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus[J]. Ther Clin Risk Manag,2017,13:515-522.

[24] DASGUPTA R,NAIK D,THOMAS N. Emerging concepts in the pathogenesis of diabetes in fibrocalculous pancreatic diabetes[J]. J Diabetes,2015,7(6):754-761.

[25] JAGANATHAN R,RAVINDRAN R,DANASEKARAN S. Emerging role of Adipocytokines in type 2 diabetes as mediators of insulin resistance and Cardiovascular disease[J]. Can J Diabetes,2018,42(4):446-456.

[26] ASGHAR A,SHELKH N. Role of innune cells in obesity induced low grade inflammation and insulin resistance[J]. Cell Immunol,2017,315:18-26

[27] OSEGBE I,OKPARA H,AZINGE E. Relationship between serum leptin and insulin resistance among obese Nigerian women[J]. Ann Afr Med,2016,l5(1):14-19.

[28] WEI YQ,LI M,YU J. Research progress in the relationship between chronic inflammation and insulin resistance[J]. Clin Pathol Res,2019,39(3):640-645.(in Chinese)魏伊秋，李满，余佳．慢性炎症与胰岛素抵抗机制关系的研究进展[J]．临床与病例杂志，2019,39(3):640-645.

[29] FANG ZW,DING HX. Effect of intensive hypoglycemic regimens on blood glucose variability in patients with severe pancreatitis[J]. Chin J Pancreatol,2016,16(6):404-406.(in Chinese)范志伟，丁惠霞．强化降糖方案对重症急性胰腺炎患者血糖变异性的影响[J]．中华胰腺病杂志，2016,16(6):404-406.

[30] de-FREITAS-JUNIOR JCM,ANDRADE-DA-COSTA J,SILVA MC,et al. Glycans as regulatory elements of the insulin/IGF system:Impact in cancer progression[J]. Int J Mol Sci,2017,18(9):1921.

[31] SINGH S,EARLE CC,BAE SJ,et al. Incidence of diabetes in color-ectal cancer survivors[J]. J Natl Cancer Inst,2016,108(6):djv402.

[32] OZER K,HORSANALI MO,GORGEL SN,et al. Diabetes is an important risk factor for metastasis in non-muscle-invasive bladder cancer[J]. Asian Pac J Cancer Prev,2016,17(1):105-108

[33] DA BM,GRONDECKA A. Diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population[J]. Arch Med Sci,2017,13(5):1025-1030.

[34] AMUTHA P,RAJKUMAR T. Role of insulin-like growth factor,insulin-like growth factor receptors,and insulin-like growth factor-binding proteins in ovarian cancer[J]. Indian J Med Paediatr Oncol,2017,38(2):198-206.

[35] DELL AE,FULGENZI CAM,MINELLI A,et al. Prognostic and predictive factors in Pancreatic cancer[J]. Oncotarget,2020,11(10):924-941.

[36] REN HT,LI RP,WANG YJ. Complications after pancreaticoduodenectomy in pancreatic cancer patients with diabetes mellitus[J]. Pract Clin Med,2016,17(5):27-29.(in Chinese)任浩棠，李瑞平，王毅钧．胰腺癌并糖尿病患者行胰十二指肠切除术后并发症的研究[J]．实用临床医学杂志，2016,17(5):27-29.

施引文献

资源附件(0)

访问统计